Alvin Chang M.D., Luis Pina M.D., Donovan Harris M.D., Craig Wood M.S., Vladan Obradovic M.D., David M. Parker M.D.
{"title":"Biliopancreatic diversion with duodenal switch results in superior weight loss and diabetes remission in patients with baseline body mass index ≥50","authors":"Alvin Chang M.D., Luis Pina M.D., Donovan Harris M.D., Craig Wood M.S., Vladan Obradovic M.D., David M. Parker M.D.","doi":"10.1016/j.soard.2024.11.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Patients with body mass index (BMI) ≥50 have more obesity-associated medical problems and often require more aggressive surgical management. Few single-institution comparative studies have been published examining this specific population.</div></div><div><h3>Objectives</h3><div>The study aims to compare the weight loss and diabetes remission effects of sleeve gastrectomy (SG), Roux-en-<span>Y</span> gastric bypass (RYGB), and biliopancreatic diversion with duodenal switch (BPD/DS).</div></div><div><h3>Setting</h3><div>Rural academic tertiary care center.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study using prospectively collected data. All patients with a BMI ≥50 who underwent an SG, RYGB, and BPD/DS were included. Comparative analysis was performed for complications, readmission rates, weight loss, and diabetes remission.</div></div><div><h3>Results</h3><div>Excess weight loss at 3 years was 40.1% for SG, 54.1% for RYGB, and 67.4% for BPD/DS, with BPD/DS performing significantly better (<em>P</em> < .001). Complete diabetes remission at 5 years was 29% for SG, 61% for RYGB, and 79% for BPD/DS. BPD/DS had significantly longer operative times (<em>P</em> < .001) and rates of minor complications (<em>P</em> = .02).</div></div><div><h3>Conclusions</h3><div>BPD/DS achieved superior sustained weight loss and diabetes remission compared with RYGB and SG.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 5","pages":"Pages 548-553"},"PeriodicalIF":3.5000,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery for Obesity and Related Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1550728924009109","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Patients with body mass index (BMI) ≥50 have more obesity-associated medical problems and often require more aggressive surgical management. Few single-institution comparative studies have been published examining this specific population.
Objectives
The study aims to compare the weight loss and diabetes remission effects of sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), and biliopancreatic diversion with duodenal switch (BPD/DS).
Setting
Rural academic tertiary care center.
Methods
We conducted a retrospective cohort study using prospectively collected data. All patients with a BMI ≥50 who underwent an SG, RYGB, and BPD/DS were included. Comparative analysis was performed for complications, readmission rates, weight loss, and diabetes remission.
Results
Excess weight loss at 3 years was 40.1% for SG, 54.1% for RYGB, and 67.4% for BPD/DS, with BPD/DS performing significantly better (P < .001). Complete diabetes remission at 5 years was 29% for SG, 61% for RYGB, and 79% for BPD/DS. BPD/DS had significantly longer operative times (P < .001) and rates of minor complications (P = .02).
Conclusions
BPD/DS achieved superior sustained weight loss and diabetes remission compared with RYGB and SG.
期刊介绍:
Surgery for Obesity and Related Diseases (SOARD), The Official Journal of the American Society for Metabolic and Bariatric Surgery (ASMBS) and the Brazilian Society for Bariatric Surgery, is an international journal devoted to the publication of peer-reviewed manuscripts of the highest quality with objective data regarding techniques for the treatment of severe obesity. Articles document the effects of surgically induced weight loss on obesity physiological, psychiatric and social co-morbidities.